Scarica l'app Stockscreener
27.57
4.77%
-1.38
Dopo l'orario di chiusura:
27.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$28.95
Aprire:
$29.06
Volume 24 ore:
444.00K
Relative Volume:
1.19
Capitalizzazione di mercato:
$981.90M
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-28.72
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
-9.37%
1M Prestazione:
-17.38%
6M Prestazione:
-35.43%
1 anno Prestazione:
+152.01%
Intervallo 1D:
$26.79
$29.08
Intervallo di 1 settimana:
$26.79
$31.54
Portata 52W:
$9.30
$59.23
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
102 WOODMONT BLVD, NASHVILLE, CA
Confronta HROW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
27.57 | 981.90M | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
Implied Volatility Surging for Harrow (HROW) Stock Options - Nasdaq
Harrow (NASDAQ:HROW) shareholders have earned a 40% CAGR over the last five years - Yahoo Finance
Shareholders Should Be Pleased With Harrow, Inc.'s (NASDAQ:HROW) Price - Simply Wall St
Equitable Trust Co. Sells 14,670 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 5.1%Here's What Happened - MarketBeat
Bleakley Financial Group LLC Buys 3,394 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
What is HC Wainwright's Forecast for Harrow Q4 Earnings? - MarketBeat
HC Wainwright Comments on Harrow’s Q4 Earnings (NASDAQ:HROW) - Defense World
Harrow (NASDAQ:HROW) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
H.C. Wainwright sets $57 target on Harrow Health stock - MSN
HC Wainwright & Co. Initiates Coverage of Harrow (HROW) with Buy Recommendation - MSN
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
15,448 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Sonora Investment Management Group LLC - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.6%Here's What Happened - MarketBeat
Fungal Keratitis Treatment Market Growth By 2031 | Harrow Inc., - openPR
SG Americas Securities LLC Acquires 18,815 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
SG Americas Securities LLC Boosts Stake in Harrow, Inc. (NASDAQ:HROW) - Defense World
Commit To Buy Harrow At $23, Earn 18% Annualized Using Options - Nasdaq
Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 - GlobeNewswire Inc.
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients - Business Wire
Harrow Launches 'Harrow Cares' Patient Support Program with Cencora Partnership - StockTitan
Harrow, Inc. (NASDAQ:HROW) Sees Board Member Resignation - Defense World
Opaleye Management Inc. Significantly Reduces Stake in Harrow Inc. - GuruFocus.com
Opaleye management sells $711,814 worth of Harrow shares By Investing.com - Investing.com South Africa
Harrow (NASDAQ:HROW) Trading Down 4.9%Time to Sell? - MarketBeat
Assenagon Asset Management S.A. Sells 79,071 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Brookstone Capital Management Invests $275,000 in Harrow, Inc. (NASDAQ:HROW) - Defense World
Brookstone Capital Management Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.1%Should You Sell? - MarketBeat
JPMorgan Chase & Co. Purchases 194,480 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Harrow appoints new Chief Scientific Officer - Investing.com
Harrow announces Amir Shojaei, PharmD, PhD joins as CSO - TipRanks
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer - Business Wire
Principal Financial Group Inc. Takes Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Inc (NASDAQ: HROW): On Track To A Higher Share Price - Stocks Register
Those Derisked Baby Bonds Of Harrow, Inc (NASDAQ:HROWM) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Up 7.7%Should You Buy? - MarketBeat
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.92%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):